Digital pathology and artificial intelligence (AI) hold immense transformative potential to revolutionize cancer diagnostics, treatment outcomes, and biomarker discovery. Gaining a deeper understanding of deep learning algorithm methods applied to histopathological data and evaluating…
Continue Reading
We developed a named entity (NE) framework for information extraction from semi-structured clinical notes retrieved from The Cancer Genome Atlas—Thyroid Cancer (TCGA-THCA) database and examined Large Language Models (LLMs) strategies to classify the 8th…
Continue Reading
The study introduces a clinical decision support system (CDSS) developed at a single academic cancer center, integrating real-time clinical, genomic, and imaging data for over 170,000 patients across 11 cancer types. We have developed…
Continue Reading
Harrison.ai has recently raised a total of $112 million in a Series C funding round led by Aware Super, ECP, and Horizons Ventures. The earlier reported $20 million investment from the Australian government’s National Reconstruction…
Continue Reading
Guy’s and St Thomas’ NHS Foundation Trust is using manual data extraction for key reporting tasks, owing to issues with its £450 million Epic electronic patient record (EPR) system.
A trust board paper, published on…
What You Should Know:
– Paige, a provider of AI-powered pathology solutions, today announced a significant expansion of Paige PanCancer Detect, its groundbreaking cancer detection tool.
– Originally launched in 2024 with the ability to identify…
Continue Reading
What You Should Know:
– PathAI, a provider of AI-powered pathology solutions, today announced the launch of PathAssist Derm, an innovative tool designed to streamline the analysis of skin lesions.
– Available now on the AISight®…
Continue Reading
The confluence of new technologies with artificial intelligence (AI) and machine learning (ML) analytical techniques is rapidly advancing the field of precision oncology, promising to improve diagnostic approaches and therapeutic strategies for patients with…
Continue Reading
Dr. Eyal Zimlichman, founder and director of ARC Innovation, a global healthcare innovation testbed, and chief innovation and transformation officer at Israel’s Sheba Medical Center, is a leading voice in healthcare IT.He sees provider-facing…
Continue Reading
Groundbreaking AI Study Transforms Cancer Diagnostics
Lunit, in partnership with Japan’s National Cancer Center Hospital East (NCCHE), has published breakthrough research in the Journal of Clinical Oncology Precision Oncology. Their study demonstrates how AI-powered pathology…
